Jackd Newman News Today

Amyris, Inc. (NASDAQ:AMRS – Get Rating) was the recipient of some unusual options trading activity on Thursday. Investors bought 9,623 put options on the stock. This is an increase of 48% compared to the average daily volume of 6,507 put options. Insider Buying and Selling at Amyris In other Amyris news, COO Eduardo Alvarez sold […]

Amyris (NASDAQ:AMRS – Get Rating) was downgraded by research analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report issued on Thursday, The Fly reports. They currently have a $0.65 price target on the biotechnology company’s stock, down from their previous price target of $3.10. Jefferies Financial Group’s price […]

TD Cowen lowered shares of Amyris (NASDAQ:AMRS – Get Rating) from an outperform rating to a market perform rating in a report released on Wednesday morning, Marketbeat.com reports. TD Cowen currently has $1.25 target price on the biotechnology company’s stock, down from their previous target price of $4.00. Several other research analysts have also commented […]

Amyris (NASDAQ:AMRS – Get Rating) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 9th. Analysts expect Amyris to post earnings of ($0.37) per share for the quarter. Amyris has set its FY 2023 guidance at EPS.Persons that wish to listen to the company’s earnings conference call can do […]

Canaccord Genuity Group began coverage on shares of Amyris (NASDAQ:AMRS – Get Rating) in a report published on Friday morning, Briefing.com reports. The brokerage issued a buy rating and a $1.50 price target on the biotechnology company’s stock. A number of other equities analysts have also weighed in on the company. Piper Sandler lowered their […]

Amyris, Inc. (NASDAQ:AMRS – Get Rating) has received a consensus rating of “Hold” from the nine ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average […]

Amyris (NASDAQ:AMRS – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $1.50 to $1.00 in a report issued on Wednesday, The Fly reports. Piper Sandler’s price target indicates a potential upside of 39.37% from the company’s previous close. AMRS has been the subject of several other research reports. HC […]

Wall Street brokerages forecast that Amyris, Inc. (NASDAQ:AMRS – Get Rating) will announce sales of $65.45 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Amyris’ earnings, with estimates ranging from $54.90 million to $85.00 million. Amyris posted sales of $176.86 million in the same quarter last year, […]

Amyris (NASDAQ:AMRS – Get Rating) was upgraded by StockNews.com to a “sell” rating in a research note issued on Thursday. Separately, Zacks Investment Research lowered shares of Amyris from a “hold” rating to a “strong sell” rating in a research report on Thursday, March 3rd. Two research analysts have rated the stock with a sell […]

Amyris, Inc. (NASDAQ:AMRS – Get Rating) – Oppenheimer reduced their FY2024 earnings estimates for shares of Amyris in a research note issued on Tuesday, March 1st. Oppenheimer analyst C. Rusch now anticipates that the biotechnology company will earn $0.22 per share for the year, down from their prior forecast of $0.27. Amyris (NASDAQ:AMRS – Get […]